Spiral Laminar Flow Prosthetic Bypass Graft: Medium-Term Results From a First-In-Man Structured Registry Study

被引:27
|
作者
Stonebridge, Peter A. [1 ]
Vermassen, Frank
Dick, John
Belch, Jill J. F.
Houston, Graeme
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Div Cardiovasc Res, Dundee DD1 9SY, Scotland
关键词
VASCULAR GRAFT; FEMOROPOPLITEAL BYPASS; HELICAL FLOW; BLOOD-FLOW; WALL SHEAR; VEIN; POLYTETRAFLUOROETHYLENE; PATTERNS; TRIAL; CUFF;
D O I
10.1016/j.avsg.2012.02.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A number of surgical strategies and graft enhancements have been trialled to improve the performance of prosthetic grafts. Neointimal hyperplasia may, in part, be a normal cellular response to an abnormal (turbulent) flow environment. This first-in-many study assesses the safety and medium-term patency performance of a new graft designed to induce stable laminar flow through the distal anastomosis. Method: Forty patients who required an infrainguinal bypass graft were recruited/registered from a number of centers in Belgium and The Netherlands. Thirty-nine received a Spiral Laminar Flow graft as part of a standard treatment protocol (23 above-the-knee and 16 below-the-knee bypasses). Kaplan-Meier analyses were used to calculate primary and secondary patency rates. Results: The 12-, 24-, and 30-month primary patency rates were 86%, 81%, and 81% for above-the-knee bypasses and 73%, 57%, and 57% for below-the-knee bypasses, respectively. In the case of secondary patency rates, numbers were unchanged for above-the-knee bypasses and were 86%, 64%, and 64%, respectively, for below-the-knee bypasses. There were no amputations in the study population. Conclusion: This first-in-man series shows potential for the idea of spiral flow-enhanced prosthetic grafts. As always, randomized studies are required to explore the role of different enhanced prosthetic grafts.
引用
收藏
页码:1093 / 1099
页数:7
相关论文
共 50 条
  • [31] RAPSTROMTM First-in-Man Study Long-Term Results of a Biodegradable Polymer Sustained-Release Sirolimus-Eluting Stent in De Novo Coronary Stenoses
    Kumar, Prathap
    Pillai, Ramakrishna
    Sreedharan, Madhu
    Davidson, Deepak
    Manjunath, C. N.
    Fischer, Louie
    Balakrishnan, K. P.
    D'Ascenzo, Fabrizio
    Sheiban, Imad
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2014, 27 (04) : 373 - 380
  • [32] Sirolimus-eluting cobalt-chromium stents:: two-year clinical results from first-in-man study on the Firebird 2™ stent
    Xu Bo
    Zhang Qi
    Yang Yue-jin
    Qiao Shu-bin
    Zhang Rui-yan
    Zhang Jian-sheng
    Hu Jian
    Qin Xue-wen
    Hong Tao
    Li Jian-ping
    Chen Ji-lin
    Huo Yong
    Gao Run-lin
    Shen Wei-feng
    CHINESE MEDICAL JOURNAL, 2008, 121 (06) : 492 - 497
  • [33] Longitudinal associations between metabolites and immediate, short- and medium-term exposure to ambient air pollution: Results from the KORA cohort study
    Yao, Yueli
    Schneider, Alexandra
    Wolf, Kathrin
    Zhang, Siqi
    Wang-Sattler, Rui
    Peters, Annette
    Breitner, Susanne
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 900
  • [34] Cohort study of high-intensity focused ultrasound in the treatment of localised prostate cancer treatment: Medium-term results from a single centre
    Wu, Yen-Ting
    Chiang, Po Hui
    PLOS ONE, 2020, 15 (07):
  • [35] MEDIUM-TERM ONCOLOGICAL OUTCOMES FOLLOWING ENDOSCOPIC FULL-THICKNESS RESECTION FOR T1 COLORECTAL CANCER: RESULTS FROM THE DUTCH PROSPECTIVE COLORECTAL EFTR REGISTRY
    Albers, Sander
    Zwager, Liselotte
    Van der Spek, Bas
    Schreuder, Ramon-Michel
    Perk, Lars
    Weusten, Bas
    Boonstra, Jurjen
    Van der Sluis, Hedwig
    Schwartz, Matthijs
    Vlug, Marije
    Wientjes, Caroline
    Munoz, Francisco Javier Rando
    Nagengast, Wouter
    Bekkering, Frank
    Ten Hove, Rogier
    Droste, Jochim S. Terhaar Sive
    Houben, Martin
    Seerden, Tom
    De Wijkerslooth, Thomas
    Gielisse, Eric
    Sarasqueta, Arantza Farina
    Fockens, Paul
    Bastiaansen, Barbara
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB445 - AB446
  • [36] A Novel Balanced Dual Vasopressin V1a/V2 Receptor Antagonist for Treatment of Congestive Heart Failure: Results From a First-in-Man Study
    Pimenta, Eduardo
    Jensen, Markus
    Jung, David
    Lobmeyer, Maximilian
    Schmitt, Walter
    Schaumann, Frank
    Boxnick, Stefanie
    Truebel, Hubert
    CIRCULATION, 2017, 136
  • [37] VXM01, an oral T-cell vaccine targeting the tumor vasculature: Results from a randomized, controlled, first-in-man study in pancreatic cancer patients.
    Schmitz-Winnenthal, Friedrich Hubertus
    Grenacher, Lars
    Friedrich, Tobias
    Lubenau, Heinz
    Springer, Marco
    Breiner, Klaus M.
    Hohmann, Nicolas
    Haefeli, Walter E.
    Mikus, Gerd
    Weitz, Juergen
    Ulrich, Alexis
    Buechler, Markus W.
    Knebel, Philip
    Schmidt, Thomas
    Ge, Yingzi
    Niethammer, Andreas G.
    Beckhove, Philipp
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Improved long-term coronary bypass results with a new "no touch" vein graft preparation technique: Preliminary results from an angiographic and IVUS follow-up study
    Johansson, BL
    Souza, DS
    Geijer, H
    Loesch, A
    Allared, M
    Wennerblom, B
    CIRCULATION, 2004, 110 (17) : 630 - 630
  • [39] Effects of Short- And Medium-Term Exposures to Lower Air Temperature on 71 Novel Biomarkers of Subclinical Inflammation: Results from the KORA F4 Study
    Ni, Wenli
    Breitner, Susanne
    Nikolaou, Nikolaos
    Wolf, Kathrin
    Zhang, Siqi
    Peters, Annette
    Herder, Christian
    Schneider, Alexandra
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2023, 57 (33) : 12210 - 12221
  • [40] Pharmacodynamics of OSI-027, a dual mTORC1/mTORC2 inhibitor, in tumor and surrogate tissues: Results from the expansion phase of a first-in-man study.
    Mateo, Joaquin
    Schoffski, Patrick
    Olmos, David
    Dumez, Herlinde
    Moreno, Victor
    Jie, Fei
    Poondru, Srinivasu
    Samberg, Nancy L.
    Van Tornout, Jan M.
    Kaye, Stanley B.
    LoRusso, Patricia M.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)